These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. Blanker MH; Bohnen AM; Ruud Bosch JL BJU Int; 2003 Jan; 91(1):125. PubMed ID: 12614268 [No Abstract] [Full Text] [Related]
8. The mouth in neurological disorders. Scully Cbe C; Shotts R Practitioner; 2001 Jun; 245(1623):539, 542-6, 548-9. PubMed ID: 11436264 [No Abstract] [Full Text] [Related]
9. Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part I). Bahbah EI; Kamal MA CNS Neurol Disord Drug Targets; 2021; 20(7):572-573. PubMed ID: 34814814 [No Abstract] [Full Text] [Related]
10. Usefulness of polysomnography in epilepsy patients. Malow BA; Fromes GA; Aldrich MS Neurology; 1997 May; 48(5):1389-94. PubMed ID: 9153478 [TBL] [Abstract][Full Text] [Related]
12. Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist? Veauthier C; Paul F Mult Scler; 2012 Feb; 18(2):248-9. PubMed ID: 21652611 [No Abstract] [Full Text] [Related]
13. Confusions concerning sleep disorders and the epilepsies in children and adolescents. Stores G Br J Psychiatry; 1991 Jan; 158():1-7. PubMed ID: 2015429 [No Abstract] [Full Text] [Related]
14. Nocturnal symptom complex in PD and its management. Chaudhuri KR Neurology; 2003 Sep; 61(6 Suppl 3):S17-23. PubMed ID: 14504376 [No Abstract] [Full Text] [Related]
15. Dopamine agonists and sleep in Parkinson's disease. Cantor CR; Stern MB Neurology; 2002 Feb; 58(4 Suppl 1):S71-8. PubMed ID: 11909988 [TBL] [Abstract][Full Text] [Related]
16. Sleep-related violence, injury, and REM sleep behavior disorder in PD. Bernath O; Guilleminault C Neurology; 1999 Jun; 52(9):1924. PubMed ID: 10371559 [No Abstract] [Full Text] [Related]
17. Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II). Kamal MA; Bahbah EI CNS Neurol Disord Drug Targets; 2021; 20(8):674-676. PubMed ID: 34844529 [No Abstract] [Full Text] [Related]